Eurolife Healthcare will have a pan-India FFS Infusions manufacturing presence in Maharashtra, Tamil Nadu and Uttarakhand
Pharma firm Eurolife Healthcare has acquired the Form-Fill-Seal (FFS) Infusion business from Baxter India for an undisclosed sum.
Baxter India is a subsidiary of Baxter International, a global medical products company. Post-acquisition, Eurolife Healthcare, a market leader in the FFS Infusions business, will own Baxters IV solutions plants in Maharashtra and Tamil Nadu, a company statement said here.
The acquisition will allow Eurolife to consolidate its position as a prominent player in the FFS Infusions segment and expand its FFS infusion manufacturing capacity to meet the evolving needs of the domestic and global FFS infusion market segments.
Following the closure of the transaction, Eurolife Healthcare will have a pan-India FFS Infusions manufacturing presence in Maharashtra, Tamil Nadu and Uttarakhand. The expanded geographic footprint will enable Eurolife to service its local distribution network more efficiently and substantially reduce time-to-market to distributors, hospitals and patients, it said.
It will also help meet the growing demand for Eurolifes products from its export distribution network spread over 22 countries.
Sandeep Toshniwal, CEO, Eurolife Healthcare said, “We welcome Baxter Indias employees and partners to the Eurolife family, and look forward to propelling Brand Eurolife to even higher levels together.”
The transaction is subject to customary closing conditions and is expected to be over by the end of the year.